Bachem AG and GlyTech, Inc. announce co-promotion agreement

October 07, 2014

Bubendorf/Basel, October 7, 2014 – Bachem the leading peptide manufacturer, and GlyTech Inc. (Kyoto, Japan), the world-leading developer of glycosylated drugs, announced today that they have entered into a co-promotion agreement for GlyTech’s glycosylation technology. As part of the agreement, Bachem will leverage its sales and marketing resources to enhance GlyTech’s partnering efforts and GlyTech will promote Bachem as the partner of choice for manufacture of its glycopeptides and glycoproteins.

Careers

At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.

View all jobs

Click here >>

Contact us